Lauren Kristen Dodd, PA
Physician Assistant · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Ut Southwestern University Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lauren Kristen Dodd’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A22553 · Cancelled
Licence status: Cancelled · since 1967 · University of California San Francisco School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ut of Texas Southwestern University Hospital - William P. Clements Jr.Dallas, TXAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of The University of Texas System, which runs 7 hospitalsHome of Harold C. Simmons Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 3.5 (2.54 to 4.46) · 4,552 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 136.98 (103.42 to 170.53) · 314 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.416, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.582, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.258, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.466, Oct 2024 – Sep 2025
See every measure and the patient survey for Ut of Texas Southwestern University Hospital - William P. Clements Jr.
Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 0 better, 7 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.5 (2.54 to 4.46) · 4,552 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 136.98 (103.42 to 170.53) · 314 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.416 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.582 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.258 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.466 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.65 to 2.02) · 4,279 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.13 (0.96 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.1 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.3 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7 · 566 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.1 · 628 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 319 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.4 · 5,756 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.07 to 0.4) · 14,917 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.12 to 0.45) · 16,518 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.98 to 5.69) · 5,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0.29 to 2.22) · 3,181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.48 (5.62 to 11.34) · 3,127 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.11 (4.25 to 7.97) · 3,175 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.43 to 2.99) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.89 (0.53 to 1.25) · 13,807 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 105 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.084 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.59 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 199 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.2 · 1,065 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 24.6 · 132 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 11.4 · 688 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 21.3 · 653 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 861 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.6 (3.7 to 5.6) · 1,345 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (9.8 to 12.9) · 1,345 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 115 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.8 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15.9 (13 to 19.5) · 3,124 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,588 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,378 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 83% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 72% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$30,232
Medicare paid this office $30,232 for 268 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 159 | $14,160 | $87 |
| New patient visit (45+ min) | 76 | $8,459 | $111 |
| New patient visit (30+ min) | 22 | $1,880 | $85 |
| Vaccine for hepatitis b (3 dose schedule) for injection into muscle, 10 mcg dosage | 15 | $1,302 | $72 |
| Administration of hepatitis b vaccine | 24 | $1,015 | $36 |
Who their Medicare patients are
268 Original Medicare patients in 2024. Average age 72 · Women 55% · Health risk score 0.58. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 39% · Coronary heart disease 16% · Diabetes 15% · Cancer 12% · Atrial fibrillation 8% · Chronic kidney disease 6% · Depression 4%.
The office billed $122,898, Medicare allowed $42,411 and paid $30,232; for 338 services of 13 kinds; $4,189 of it was for drugs given in the office and $26,042 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 268 | 338 | 72 | 0.58 | $122,898 | $30,232 |
| 2023 | 76 | 82 | 73 | 0.54 | $35,423 | $7,036 |
| 2022 | 114 | 130 | 73 | 0.61 | $40,319 | $12,745 |
| 2021 | 54 | 73 | 70 | 0.68 | $20,071 | $7,936 |
| 2020 | 62 | 67 | 73 | 0.64 | $15,334 | $3,639 |
| 2019 | 30 | 38 | 72 | 0.50 | $8,748 | $2,410 |
| 2017 | 13 | 15 | 80 | 1.12 | $3,094 | $202 |
| 2016 | 292 | 848 | 78 | 1.47 | $35,535 | $8,141 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| New patient visit (45+ min) | 35 | $4,084 | $117 |
| Return visit (30+ min) | 30 | $2,235 | $74 |
2022: 4 services
| New patient visit (30+ min) | 29 | $2,449 | $84 |
| Return visit (30+ min) | 18 | $2,067 | $115 |
| Long return visit (40+ min) | 12 | $1,927 | $148 |
| New patient visit (15+ min) | 19 | $1,138 | $60 |
2021: 1 service
| Return visit (30+ min) | 16 | $1,814 | $113 |
2020: 3 services
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,257 | $114 |
| Return visit (30+ min) | 25 | $1,135 | $45 |
| Short return visit (20+ min) | 20 | $432 | $22 |
2019: 1 service
| Return visit (30+ min) | 19 | $1,617 | $85 |
2016: 3 services
| Blood test, clotting time | 228 | $3,922 | $5 |
| Short return visit (20+ min) | 38 | $1,836 | $47 |
| Return visit (30+ min) | 18 | $1,401 | $67 |
Medicaid work
$7,944 in 2019
Medicaid paid $7,944 for 41 billed services this clinician did in 2019, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 41 | $7,944 |
| 2019 | 41 | 1 | 34 | $7,944 |
| 2018 | 339 | 4 | 62 | $44,584 |
See the largest Medicaid services in earlier years
2018
| Clinic visit/encounter, all-inclusive | 220 | $43,990 |
| Short return visit (20+ min) | 64 | $330 |
| Return visit (30+ min) | 40 | $234 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 15 | $29 |
Drugs they prescribed that Part D paid
$19,935
Pharmacies billed $19,935 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
346 generic and 66 brand-name prescriptions · $19,935 in drug cost · 196 antibiotic prescriptions to 182 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atovaquone-Proguanil | 140 | $12,310 | $85 |
| Azithromycin | 170 | $471 | $3 |
| Acetazolamide | 25 | $316 | $12 |
Year by year
| 2024 | 412 | 235 | None | 16% | $19,935 |
| 2023 | 130 | 74 | 0% (0) | 24% | $11,763 |
| 2022 | 145 | 82 | 0% (0) | 13% | $11,571 |
| 2021 | 88 | 51 | 0% (0) | 25% | $6,570 |
| 2020 | 59 | 37 | 0% (0) | None | $2,503 |
| 2019 | 189 | 101 | 0% (0) | 23% | $8,907 |
| 2018 | 49 | 26 | 0% (0) | None | $1,194 |
| 2017 | 81 | 33 | None | None | $5,401 |
| 2016 | 589 | 179 | 3% (18) | None | $43,535 |
| 2015 | 1,162 | 240 | 7% (78) | 19% | $58,836 |
| 2014 | 715 | 210 | 4% (29) | None | $49,154 |
| 2013 | 497 | 162 | 3% (17) | None | $35,640 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Atovaquone-Proguanil | 49 | $4,491 | $92 |
| Azithromycin | 53 | $220 | $4 |
2022: 3 drugs
| Atovaquone-Proguanil | 46 | $5,052 | $110 |
| Azithromycin | 62 | $295 | $5 |
| Acetazolamide | 12 | $177 | $15 |
2021: 2 drugs
| Atovaquone-Proguanil | 32 | $2,447 | $76 |
| Azithromycin | 37 | $212 | $6 |
2020: 2 drugs
| Atovaquone-Proguanil | 19 | $1,359 | $72 |
| Azithromycin | 29 | $172 | $6 |
2019: 2 drugs
| Atovaquone-Proguanil | 52 | $3,995 | $77 |
| Azithromycin | 68 | $483 | $7 |
2016: 14 drugs
| Hydrocodone-Acetaminophen | 14 | $471 | $34 |
| Atorvastatin | 26 | $400 | $15 |
| Omeprazole | 23 | $271 | $12 |
| Levothyroxine | 11 | $262 | $24 |
| Metoprolol | 12 | $216 | $18 |
| Carvedilol | 21 | $213 | $10 |
| Gabapentin | 17 | $181 | $11 |
| Lisinopril | 24 | $140 | $6 |
| Metformin | 19 | $136 | $7 |
| Warfarin | 17 | $107 | $6 |
| Alendronate | 19 | $106 | $6 |
| Glipizide | 17 | $101 | $6 |
| Azithromycin | 15 | $91 | $6 |
| Losartan | 15 | $74 | $5 |
2015: 32 drugs
| Lantus | 12 | $6,304 | $525 |
| Januvia | 12 | $5,386 | $449 |
| Hydrocodone-Acetaminophen | 63 | $1,865 | $30 |
| Proair Hfa | 19 | $965 | $51 |
| Nitrostat | 28 | $768 | $27 |
| Omeprazole | 40 | $684 | $17 |
| Levothyroxine | 24 | $612 | $26 |
| Atorvastatin | 31 | $416 | $13 |
| Lisinopril | 54 | $383 | $7 |
| Carisoprodol | 16 | $338 | $21 |
| Fluoxetine | 24 | $294 | $12 |
| Gabapentin | 38 | $293 | $8 |
| Temazepam | 13 | $286 | $22 |
| Metformin | 43 | $271 | $6 |
| Alendronate | 35 | $265 | $8 |
| Zolpidem | 13 | $249 | $19 |
| Glipizide | 33 | $220 | $7 |
| Atenolol | 16 | $199 | $12 |
| Carvedilol | 19 | $170 | $9 |
| Losartan | 20 | $164 | $8 |
| Azithromycin | 23 | $140 | $6 |
| Pantoprazole | 12 | $120 | $10 |
| Simvastatin | 12 | $117 | $10 |
| Furosemide | 34 | $113 | $3 |
| Hydrochlorothiazide | 20 | $109 | $5 |
| Alprazolam | 28 | $104 | $4 |
| Amlodipine Besylate | 16 | $94 | $6 |
| Lorazepam | 20 | $88 | $4 |
| Clonidine | 15 | $79 | $5 |
| Trazodone | 13 | $78 | $6 |
| Amoxicillin | 17 | $66 | $4 |
| Diazepam | 11 | $56 | $5 |
2014: 17 drugs
| Hydrocodone-Acetaminophen | 26 | $708 | $27 |
| Tamsulosin | 11 | $379 | $34 |
| Simvastatin | 31 | $318 | $10 |
| Losartan | 17 | $303 | $18 |
| Atorvastatin | 19 | $294 | $15 |
| Omeprazole | 34 | $292 | $9 |
| Metformin | 15 | $287 | $19 |
| Temazepam | 11 | $261 | $24 |
| Lovastatin | 11 | $181 | $16 |
| Lisinopril | 20 | $161 | $8 |
| Gabapentin | 16 | $147 | $9 |
| Azithromycin | 13 | $141 | $11 |
| Carvedilol | 11 | $136 | $12 |
| Furosemide | 30 | $120 | $4 |
| Alendronate | 15 | $112 | $7 |
| Alprazolam | 17 | $102 | $6 |
| Amlodipine Besylate | 16 | $67 | $4 |
2013: 7 drugs
| Tamsulosin | 12 | $439 | $37 |
| Gabapentin | 17 | $343 | $20 |
| Metformin | 17 | $300 | $18 |
| Simvastatin | 20 | $257 | $13 |
| Omeprazole | 17 | $223 | $13 |
| Alendronate | 12 | $117 | $10 |
| Furosemide | 12 | $62 | $5 |
Professional record
- NPI
- 1932451663
- Licence
- CA 22553California A22553: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2012-10-04
- NPI last updated
- 2022-04-06
- NPI record certified
- 2022-04-06
This is when the NPI record was last certified, not a medical board exam.